We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current EYES market cap is 211.24M. The company's latest EPS is USD -0.5027 and P/E is -2.37.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -7.14M | -6.22M | -6.23M | -5.68M | -6.31M |
| Net Income | -6.78M | -6.03M | -6.04M | -5.36M | -6.04M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 3.38M | 0 | 0 | 0 | 0 |
| Operating Income | -33.95M | -15.9M | -8.93M | -21.24M | -26.97M |
| Net Income | -33.59M | -15.88M | -8.92M | -13.89M | -25.65M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 53.32M | 45.8M | 53.79M | 48.22M | 42.9M |
| Total Liabilities | 27.11M | 25.04M | 25.08M | 24.4M | 24.56M |
| Total Equity | 26.21M | 20.76M | 28.71M | 23.82M | 18.33M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 16.6M | 4.46M | 70.88M | 51.13M | 45.8M |
| Total Liabilities | 9.32M | 5.13M | 2.51M | 6.82M | 25.04M |
| Total Equity | 7.28M | -672k | 68.37M | 44.31M | 20.76M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -20.22M | -23.7M | -4.51M | -9.31M | -14.97M |
| Investing | -144k | -887k | -182k | -219k | -260k |
| Financing | 110k | 133k | 13.69M | 13.8M | 14.23M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -27.63M | -16.82M | -9.19M | -18.79M | -23.7M |
| Investing | -493k | 68k | -14k | -338k | -887k |
| Financing | 34.99M | 8.6M | 75.61M | 63.39M | 133k |
| Market Cap | 211.24M |
| Price to Earnings Ratio | -2.37 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 2.94 |
| Price to Book Ratio | 2.92 |
| Dividend Yield | - |
| Shares Outstanding | 51.03M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | - |
| 52 Week High | - |
| 52 Week Low | - |
| Spread (Intraday) | 0.09 (2.13%) |
| Company Name | Second Sight Medical Products Inc |
| Address |
5858 horton street emeryville, california 94608 |
| Website | https://www.vivani.com |
| Industry | med, dental, hosp eq-whsl (5047) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
